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Abstract
 
Infections are a leading cause of death in stroke patients. In a mouse model of focal cerebral
ischemia, we tested the hypothesis that a stroke-induced immunodeficiency increases the sus-
ceptibility to bacterial infections. 3 d after ischemia, all animals developed spontaneous septicemia
and pneumonia. Stroke induced an extensive apoptotic loss of lymphocytes and a shift from T
helper cell (Th)1 to Th2 cytokine production. Adoptive transfer of T and natural killer cells
from wild-type mice, but not from interferon (IFN)-
 
 
 
–deficient mice, or administration of
IFN-
 
  
 
at day 1 after stroke greatly decreased the bacterial burden. Importantly, the defective
IFN-
 
  
 
response and the occurrence of bacterial infections were prevented by blocking the
 
sympathetic nervous system but not the hypothalamo-pituitary-adrenal axis. Furthermore, admin-
istration of the 
 
 
 
-adrenoreceptor blocker propranolol drastically reduced mortality after stroke.
These data suggest that a catecholamine-mediated defect in early lymphocyte activation is the
key factor in the impaired antibacterial immune response after stroke.
Key words: T lymphocytes • natural killer cells • interferon 
 
  
 
• pneumonia • brain ischemia
 
Introduction
 
Infectious complications, predominantly chest and urinary
tract infections, have been reported to occur in 23–65% of
all stroke patients within the first few days after stroke (1–5).
Although early mortality is due to direct complications
from large strokes, pneumonia is the leading cause of death
in the postacute phase of stroke, regardless of hospitalization
(6–9). The high frequency of antibiotic treatment on spe-
cialized stroke units underlines the clinical problem of infec-
tions in stroke patients (10). The high incidence of infec-
tions in these patients is likely to be a result of an impaired
immune function. Immunodepression has been reported in
other potentially life-threatening conditions, such as myo-
cardial infarction, polytrauma, or major surgery, resulting
in an increased risk of infectious complications (11–13). In
trauma patients, the presence of brain injury was identified
as an independent risk factor for infectious complications,
possibly due to a central nervous shutdown of the immune
defense (14, 15). As early as 1974, an immunosuppressive
state was associated with stroke (16). However, the mecha-
nisms leading to an increased susceptibility to infections after
stroke are still poorly understood. Here, we demonstrate
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that focal cerebral ischemia induces a rapid and long-lasting
inhibition of cell-mediated immunity resulting in sponta-
neous systemic bacterial infection, and that early IFN-
 
 
 
production by T and NK cells is crucial in controlling bac-
terial infections. Our finding that 
 
 
 
-adrenoreceptor block-
ade enhances cellular immune responses and prevents bac-
terial infections, provides strong evidence that an activation
of the sympathetic nervous system (SNS) is the main im-
munosuppressive mechanism leading to a high incidence of
infections after stroke.
 
Materials and Methods
 
Animals.
 
SV129/J mice (BGVV), B6.129P2-Tcrb
 
tm1Mom 
 
(
 
  
 
T cell–deficient), B6.129P2-Tcrd
 
tm1Mom 
 
(
 
   
 
T cell–deficient),
B6.129S7-INF
 
 
 
tm1Ts 
 
(IFN-
 
 
 
–deficient), and C57BL/6J wild-type
mice (The Jackson Laboratory) were housed in the animal care
facility at the Department of Neurology (Charité Hospital, Ber-
lin, Germany) until killed.
 
Experimental Model of Stroke.
 
We used gender-mixed 7-wk-
old or older SV129/J or, where indicated, C57BL/6J mice weigh-
ing 
 
 
 
18–22 g. The surgical procedure of middle cerebral artery
occlusion (MCAO) did not exceed 10 min and was induced as
previously described (17). In brief, a monofilament was introduced
into the common carotid artery under halothane narcosis, ad-
vanced to the origin of the middle cerebral artery (MCA), and left
there for 60 min until reperfusion. In sham-operated animals, after
inserting the filament to the MCA origin, the filament was imme-
diately withdrawn by 2 mm to avoid ischemia. Occlusion and re-
perfusion were verified by laser Doppler flowmetry (Peri Flux 4001
Master; Perimed). Mice were kept in heated cages for the next 2 h
and body temperature was frequently measured. Animals were
then returned to their home cages and allowed free access to food
and water. The infarct volumes were measured histologically as
previously described (18). All animal experiments were performed
according to institutional and state guidelines.
 
Drug Administration.
 
All drugs were injected i.p. and the re-
spective diluents were given to the control animals at the same
time. RU486 (Sigma-Aldrich) was dissolved in ethanol/sesame
oil solution (1:10 vol/vol) at 6 mg/ml and administered (30 mg/
kg body weight) 24 h, 5 h, and immediately before MCAO. Pro-
pranolol (Sigma-Aldrich) was dissolved in 0.9% sodium chloride
at 6 mg/ml, and administered (dose 1–30 mg/kg body weight as
indicated) immediately before as well as 4 and 8 h after MCAO.
Where indicated, propranolol administration (30 mg/kg body
weight) was delayed and given 24, 28, and 32 h after MCAO.
6-hydroxydopamine HBr (6-OHDA; Sigma-Aldrich) was dis-
solved in sterile 0.01% ascorbic acid/saline and injected (200 mg/
kg body weight) 3 d before MCAO. IFN-
 
  
 
(TEBU) was dis-
solved in phosphate buffered saline at 20 
 
 
 
g/ml, and adminis-
tered i.p. (2 
 
 
 
g) at 24 and/or 48 h after MCAO. Control mice
received heat-denaturated IFN-
 
  
 
solution.
 
Blood Samples, Cell Suspensions, and Cell Count.
 
Mice were
killed and blood was collected into heparinized tubes. Single cell
suspensions from thymus and spleen were prepared by forcing the
tissues through a fine wire mesh. Cells were washed and resus-
pended in 2 ml RPMI 1640 medium containing penicillin, strep-
tomycin, 2 mM glutamine, and 10% FCS (Biochrom KG).
Residual RBCs were lysed by hypotonic lysis in ice-cold ammo-
nium. Cell counts were performed in triplicates.
 
Flow Cytometry.
 
For flow cytometric analysis the following
fluorescently labeled anti–mouse monoclonal antibodies (BD
 
Biosciences) were used: CD3 (145-2C11; T cells), CD4 (L3T4),
CD8 (Ly-2), CD45R (RA3-6B2; B cells), anti–pan-NK cell
marker (DX5), CD11b (M1/70; monocytes/macrophages, gran-
ulocytes), and CD11c (HL3; dendritic cells). In blood and spleen
samples, RBCs were lysed with BD Lysis Solution (Becton Dick-
inson) before analysis. The degree of apoptotic cell death in thy-
mus and spleen single cell suspensions was quantified using fluo-
rescein-labeled annexin V (Qbiogene). Cell phenotyping and
identification of apoptotic cells was performed by four-color flow
cytometry on a FACSCalibur™ using CELLQuest™ Software
(BD Biosciences).
 
Analysis of Ex Vivo Cytokine Production.
 
Whole blood was di-
luted 1:5 in heparinized RPMI 1640 and incubated at 37
 
 
 
C and
5% CO
 
2
 
. For analysis of TNF-
 
  
 
synthesis, samples were stimu-
lated with 100 ng/ml LPS (endotoxin) from 
 
Escherichia coli
 
 0127:B8
(Sigma-Aldrich) for 4 h. For analysis of IFN-
 
  
 
and IL-4 produc-
tion, blood samples were stimulated with 100 
 
 
 
g/ml Con A
(Sigma-Aldrich) for 24 h. For analysis of IFN-
 
  
 
production in
spleen cells, 10
 
6 
 
cells/ml were stimulated with 10 
 
 
 
g/ml Con A
for 24 h. Concentrations of cytokines in culture supernatants
were determined using commercially available kits and according
to the manufacturer’s instructions (BD Biosciences). Each sample
was assayed in duplicate.
 
Adoptive Transfer of Spleen Cells.
 
Single cell suspensions were
prepared from spleens of wild-type or knockout mice as de-
scribed above. Mice that underwent MCAO were injected intra-
peritoneally with 5 
 
  
 
10
 
6 
 
splenocytes 24 h after MCAO. Control
mice were injected with medium. In some experiments, splenic
T, B, and NK cell subsets were depleted using commercially
available magnetic bead kits (CD90, CD45R, DX5 microbeads;
Miltenyi Biotec). Depletion efficacy was verified as 
 
 
 
95% by
flow cytometry.
 
Histopathological Analysis of Lung Tissue.
 
After transcardial
perfusion with ethanol-formalin-acetic acid, lungs were removed
and embedded in paraffin wax. 12-
 
 
 
m thick sections were ob-
tained by microtome dissection and stained with hematoxylin/
eosin (HE). 20 representative sections of lungs were chosen per
animal (
 
n 
 
  
 
4 in each group) and evaluated by two investigators,
who were blinded to the treatment groups. The sections were
graded according to the following criteria: no definite damage
represented no histological changes or minor changes, including
unequal distension of alveolar units, mild thickening of the alveo-
lar septa, and perivascular and peribronchiolar edema. Definite
damage was observed as lung consolidation, thickened alveolar
septae, and the presence of intra-alveolar inflammatory infiltrates.
 
Histochemistry and In Situ Terminal Deoxynucleotide Transferase-
mediated dUTP Nick-end Labeling (TUNEL) Assay.
 
After trans-
cardial perfusion with ethanol-formalin-acetic acid, thymi were
removed and embedded in paraffin wax. Sections were obtained
by microtome dissection and stained with HE. Based on HE
staining, two representative 12-
 
 
 
m sections of thymus were cho-
sen per animal (
 
n 
 
  
 
6) and processed for TUNEL. The Apoptag
Kit (Intergen) was used according to the manufacturer’s instruc-
tions. Visualization was achieved using the Vectorstain ABC elite
kit (Vector Laboratories) in conjunction with 3,3
 
 
 
-diaminobenzi-
dine/H
 
2
 
O
 
2 
 
(Sigma-Aldrich).
 
Bacteriological Analysis.
 
The anesthetized mice were washed
with 70% ethanol under sterile conditions. Blood was collected
by decapitation. The lungs were removed after thoracotomy and
homogenized. For determination of CFU, 100 
 
 
 
l tissue homo-
genate or blood was serially diluted, plated onto blood agar plates
(Merck), incubated at 37
 
 
 
C for 18 h, and bacterial colonies were
counted.T
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Statistical Analysis.
 
Bacteriological data are presented as box
plots and other data are given as mean 
 
  
 
SD. Data were analyzed
by Kruskal-Wallis analysis of variance (ANOVA) after pairwise
comparison with Dunn’s method or Mann-Whitney U test using
SPSS software (SPSS Inc.). Differences in the group survival were
determined using Fisher’s exact test. Values of P 
 
  
 
0.05 were
considered significant.
 
Results
 
Ischemia was induced in mice by temporary occlusion of
the MCAO. Sham controls received surgery identical to
that of MCAO but with regional cerebral blood flow re-
maining unaffected. After 60 min of MCAO, animals de-
veloped large infarcts (90 
 
  
 
10 mm
 
3
 
) of cortex, striatum,
and hippocampus.
 
Spontaneous Bacteremia and Pneumonia after Focal Cerebral
Ischemia.
 
3 d after ischemia, all MCAO animals suffered
from spontaneous bacterial infections. Bacterial cultures
from peripheral blood and lungs invariably demonstrated
 
 
 
95% 
 
E. coli
 
 (Fig. 1 a). Significant bacterial loads were ob-
served in lungs and blood 24 and 48 h after ischemia, re-
spectively. Histological examination of lungs revealed typi-
cal signs of bacterial pneumonia (19, 20) in all analyzed
MCAO-treated animals 72 h after experimental stroke (
 
n 
 
 
 
4, Fig. 1 b). In contrast, blood and lung cultures from
sham-operated animals remained sterile at 6, 12, 24, 48
(not depicted), and 72 h (Fig. 1 a). In addition, lung sec-
tions of sham controls revealed no signs of pneumonia (
 
n 
 
  
 
4,
Fig. 1 b). Therefore, susceptibility to infection resulted
from stroke and not from surgical stress.
 
Long-lasting Lymphopenia and Impaired Cellular Immune
Functions after Cerebral Ischemia.
 
To characterize the un-
derlying mechanisms of spontaneous infections after stroke,
we analyzed the cellularity and leukocyte populations in
lymphoid organs and peripheral blood from MCAO, sham,
and control mice using four-color flow cytometry. We
found a striking reduction of lymphocyte counts in blood,
spleen, and thymus after cerebral ischemia (Fig. 2). The ab-
solute numbers of T, B, and NK lymphocytes were de-
creased 3–10-fold in blood and 2–3-fold in spleen as early
as 12 h after MCAO (Fig. 2, a–f). There was only a mar-
ginal decrease in the number of lymphocytes in sham ani-
mals, indicating that lymphopenia was mainly caused by
ischemia and only partly due to surgical stress. The post-
ischemic total lymphocyte count in the blood was signifi-
cantly lower even after 14 d (MCAO: 2.7 
 
  
 
0.6 vs. con-
trol: 4.8 
 
  
 
0.5 
 
  
 
10
 
6
 
/ml; P 
 
  
 
0.05), whereas the number
of splenic lymphocytes remained reduced for 42 d
(MCAO: 26.9 
 
  
 
0.8 vs. control: 46.5 
 
  
 
4.7 
 
  
 
10
 
6
 
/ml;
P 
 
  
 
0.05; Fig. 2, a–f). Cellularity in the thymus was also
severely reduced (Fig. 2 g) and characterized by a rapid loss
of immature CD4
 
  
 
CD8
 
  
 
thymocytes and subsequent re-
duction in the number of mature single positive T cells
(not depicted). Interestingly, splenic T and B cell counts
increased 2 d after stroke, but dropped again at day 5 (Fig.
2, d and e) coinciding with the occurrence of bacteremia.
Recently, we have reported that patients with brain sur-
gery showed diminished monocytic HLA-DR expression
and endotoxin-induced TNF-
 
  
 
secretion as signs of sys-
temic immunodepression (13, 21). To test whether cerebral
ischemia is also associated with alterations in cellular
immune functions, we examined the endotoxin-induced
TNF-
 
  
 
secretion as well as Con A–induced IFN-
 
  
 
and IL-4
production ex vivo in whole blood cultures, as parameters of
monocyte and T lymphocyte functions, respectively. Secre-
tion of endotoxin-induced TNF-
 
  
 
was significantly de-
creased after 12 h and 2 d after MCAO but returned to con-
trol levels on day 5 (Fig. 2 h). The decrease in the
monocytic TNF-
 
  
 
release was not due to reduced mono-
cyte cell numbers, as blood monocyte counts in MCAO
animals did not differ from those in control mice (not
depicted). Furthermore, we found reduced IFN-
 
  
 
but in-
creased IL-4 production in Con A–stimulated blood cultures
Figure 1. Stroke induces bacteremia and pneumonia. (a) Lungs and
blood samples from sham (n   10) and MCAO-treated mice (n   4–14
per group) were collected for bacteriological analysis at the indicated time
points after surgery. Data are given in CFU/ml (log 10) blood or lung tis-
sue homogenate. (b) In a different set of experiments, lungs from sham-
operated (n   4) and MCAO mice (n   4) were collected after 72 h for
histological examination. A representative 12- m section of HE-stained
lung from MCAO but not from sham animals revealed signs (thickening
of alveolar walls and neutrophilic infiltrates) of E. coli pneumonia.  160.T
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resulting in a significant decrease of the IFN-
 
 
 
/IL-4 ratio for
at least 14 d after MCAO (Fig. 2 i). In contrast, sham-oper-
ated animals did not show significant alterations in any of the
measured cytokine secretion parameters (Fig. 2, h and i).
Importantly, the described alterations of immune parameters
after experimental stroke preceded bacterial infections (com-
pare Figs. 1 a and 2) and, therefore, are more likely to be the
cause than the result of bacterial infections.
 
Brain Ischemia Causes Rapid and Extensive Apoptosis in
Lymphatic Organs.
 
To test whether lymphopenia was a re-
sult of increased apoptosis, we analyzed spleen and thymus
cell suspensions by flow cytometry and found a marked in-
crease in apoptotic lymphocytes 12 h after MCAO. In sple-
nocytes, increased apoptosis affected all lymphocyte subsets,
as determined by annexin V and cell-type–specific surface
marker staining (Fig. 3 a). Similarly, enhanced apoptosis
was found in all thymocyte subsets, mostly affecting the
immature CD3
 
dim 
 
CD4
 
  CD8  double positive thymocytes
(Fig. 3 b). In contrast, there was no significant difference in
the degree of apoptosis in splenocytes from sham-operated
mice, and only a very modest increase in apoptosis in dou-
ble positive immature thymocytes was noted (Fig. 3, a and
b). In accordance with these results, light microscopic ex-
amination of thymi from MCAO mice, but not sham mice,
showed many apoptotic cells with features of pyknosis or
karyorrhexis (Fig. 3 c, top). Moreover, TUNEL staining
demonstrated that the apoptosis occurred predominantly in
the thymic cortex, which is mainly populated by immature
double positive thymocytes, and relatively spared the thy-
mic medulla (Fig. 3 c, bottom). In addition, thymocyte
DNA from MCAO animals showed extensive laddering
(not depicted).
Role of Stress Mediators in Postischemic Immunodepression.
The activation of the hypothalamic-pituitary-adrenal axis
(HPA) and the SNS, resulting in a systemic release of adre-
nal steroid hormones and catecholamines, is an essential
component of the response to major surgery, brain injury,
or trauma. As high levels of these stress mediators are
known to be immunosuppressive (22), we investigated the
effects of the  -adrenoreceptor antagonist propranolol and
Figure 2. Stroke induces long-lasting lymphopenia and impaired cytokine expression. Spleen, thymus, and peripheral blood samples of untreated
SV129/J mice (control) and sham or MCAO mice were collected at different time points (sham, 12 h; MCAO, as indicated) after surgery. Leukocyte
counts in blood (a–c), spleen (d–f), and thymus (g) single cell suspensions were determined as described in Materials and Methods. The lymphocyte sub-
sets were determined by flow cytometry and their absolute numbers were calculated. (h and i) Aliquots of blood samples were stimulated ex vivo with either
LPS for analysis of monocytic TNF-  expression or Con A for analysis of IFN-  and IL-4 synthesis, as described in Materials and Methods. Cytokines
were determined in supernatants by ELISA. The Con A–induced lymphokine expression is given as the ratio of IFN-  and IL-4 production calculated
for each individual. Data are shown as mean   SD. *, results differed from the control group; *, P   0.05; **, P   0.01; ***, P   0.001; #, results differed
from the sham-operated group; #, P   0.05; ##, P   0.01. Mann-Whitney U test, n   3–11 per group.T
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the glucocorticoid receptor inhibitor RU486 on the im-
munoinhibitory alterations induced by stroke. Treatment
of MCAO animals with either propranolol or RU486 de-
creased the percentage of apoptotic splenocytes to levels
observed in sham-operated mice and prevented the de-
crease in peripheral blood lymphocyte counts. The protec-
tive effects of both compounds extended to all lymphocyte
subsets in spleen and blood (Fig. 4, a and b). Both com-
pounds also significantly increased the ex vivo endotoxin-
induced TNF-  release, but only propranolol normalized
the IFN- /IL-4 ratio after Con A stimulation of whole
blood cultures (Fig. 4 c).
Inhibition of the SNS but Not Steroid Receptor Blockade Pre-
vents Systemic Infection. Treatment with propranolol (3  
30 mg/kg BW) completely prevented both bacteremia and
pneumonia in 8 out of 10 animals (Fig. 4 d). In the remain-
ing two mice, bacterial counts in blood and lung were re-
duced by the order of 104 and 106, respectively. In contrast,
the glucocorticoid receptor antagonist RU486 had no ef-
fect on blood or pulmonary bacterial burden. The protec-
tive effect of propranolol was dose and time dependent.
Propranolol doses (3   10 and 3   30 mg/kg BW starting
immediately after MCAO) sufficient to reduce or prevent
bacterial dissemination at 72 h after MCAO (Fig. 5 a) also
restored the defective IFN-  response determined 12 h af-
ter experimental stroke (Fig. 5 b), whereas lower doses had
no effect on either bacterial load or IFN-  production. Im-
portantly, delayed administration of propranolol (3   30
mg/kg BW starting 24 h after cerebral ischemia) neither in-
creased IFN-   production nor decreased bacterial load
(Fig. 5), demonstrating that blockade of sympathetic nerves
activation early after MCAO is crucial to prevent lympho-
cyte dysfunction and, subsequently, bacterial infections. To
confirm that the protective effect of propranolol was due to
inhibition of sympathetic nerve signaling, MCAO mice
were pretreated with 6-OHDA, which selectively enters
and destroys sympathetic noradrenergic terminals, thereby
depleting tissue catecholamines (23). Like propranolol,
chemical sympathectomy by 6-OHDA up-regulated IFN- 
production and significantly reduced bacterial load in lungs
and blood (Fig. 5).
Inhibition of the SNS Improves Survival after Experimental
Stroke. Mortality in MCAO animals sharply increased
from 13% on day 3 to 60% on day 7 after ischemia (n  
15). Because animals developed severe hypothermia be-
tween days 3 and 5 ( 33 C measured rectally, not de-
picted) accompanied by bacteremia, sepsis was the likely
cause of death. The early mortality in propranolol-treated
(3   10 mg/kg BW) and diluent-treated animals equally
amounted to  7-13% until day 3 after stroke. However,
only an additional 7% of the propranolol-treated animals
died, whereas 60% of mice treated with diluent were dead
by day 7 (P   0.02, diluent vs. propranolol; Fig. 6).
Adoptive Lymphocyte Transfer Prevents Bacterial Infections
after Stroke. Both RU486 and propranolol prevented
most of the stroke-induced immunodepressive effects ex-
cept the changes in the lymphocyte cytokine production,
which was only normalized by  -adrenoreceptor block-
ade. To test whether bacterial infection in MCAO ani-
mals was caused by the (functional) loss of lymphocytes,
we conducted a series of adoptive cell transfer experi-
Figure 3. Stroke induces increased apoptosis in lymphoid organs.
Spleen and thymus from untreated SV129/J mice (control) and sham or
MCAO mice were collected 12 h after surgery. Splenocytes (a) and thy-
mocytes (b) were isolated and investigated for apoptosis by annexin V
labeling and flow cytometry. Lymphocyte subpopulations were deter-
mined by staining with mAbs against cell-type–specific surface markers.
Data are shown as mean   SD. *, results differed from the control group;
*, P   0.05; **, P   0.01; ***, P   0.001; #, results differed from the
sham-operated group; #, P   0.05; ##, P   0.01; ###, P   0.001.
Mann-Whitney U test, n   8 per group. (c) Thymic tissue sections from
sham- and MCAO-treated mice were stained with HE (top) or examined
by the fluorescent TUNEL method (bottom). Thymi from MCAO mice
showed many apoptotic cells with typical features of nuclear condensation
and fragmentation (HE;  400). Note also the high number of TUNEL 
cells (bright red nuclei) in the thymus cortex from MCAO animals as
compared with sham mice.  100.T
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ments. 24 h after MCAO, mice received either unsepa-
rated splenocytes (5   106) or subset-depleted spleen cells
from normal littermates. Bacterial counts in blood and
lungs were determined 48 h later. Transfer of nonsepa-
rated spleen cells virtually abolished bacteremia and re-
duced pulmonary bacterial load by the order of 105 (Fig. 7
a). This effect was absent upon transfer of spleen cell sus-
pensions depleted of all lymphocyte subsets (thus contain-
ing mostly monocytes/macrophages). Depletion of B cells
only marginally affected the ability to reduce the bacterial
load. In contrast, T cell–depleted splenocytes reduced
bacteremia only by two orders of magnitude and failed to
reduce pulmonary bacterial counts. In addition, NK cell–
depleted splenocytes lowered the bacterial load signifi-
cantly in the lung but not in peripheral blood (Fig. 7 a).
To further investigate the role of specific T cell popula-
tions in the antibacterial defense, we performed adoptive
transfer studies with spleen cells (5   106) from    T
cell– or    T cell–deficient mice. Spleen cells from    T
cell knockout mice were unable to prevent pulmonary in-
fection, whereas they substantially reduced blood bacterial
dissemination (Fig. 7 b). In contrast, spleen cells from   
T cell knockout mice reduced the bacterial burden in the
lung but hardly had any effect on bacteremia. These data
indicate that T and NK lymphocytes are critical compo-
nents of the acute response to bacterial infections after
stroke. In particular,    T cells and    T cells are impor-
tant for an effective host response to bacterial pneumonia
and bacteremia, respectively.
IFN-   Is Crucial in Controlling Bacterial Infections after
Stroke. IFN-  is one of the key effector cytokines pro-
duced by NK and T cells that enhances microbicidal activ-
ity of macrophages and neutrophils. As shown above,
blockade of catecholamines restored both IFN-  pro-
duction and bacterial clearance. Therefore, we examined
whether the beneficial effect of lymphocyte transfer in
stroke-induced infections is dependent on their ability to
produce IFN- . Adoptive transfer of splenocytes from
IFN-  /  mice failed to reduce pulmonary and blood bac-
terial counts in comparison to spleen cells from wild-type
Figure 4. Effects of  -adrenoreceptor and glucocorticoid receptor
blockade on stroke-induced immunodepression and bacterial infection.
SV129/J mice underwent sham or MCAO surgery (n   9–12 per group).
MCAO mice received the  -adrenoreceptor antagonist propranolol, the
glucocorticoid receptor inhibitor RU486, or only diluent before or after
surgery, as described in Materials and Methods. Spleens and blood samples
were collected 12 h after surgery. (a) Splenocytes were isolated and inves-
tigated for apoptosis by annexin V labeling, staining with mAbs against
cell-type–specific surface markers, and flow cytometry. (b) Total leuko-
cyte counts in blood samples were determined as described in Materials
and Methods. The percentages of different lymphocyte classes were deter-
mined by flow cytometry using mAbs against cell-type–specific surface
markers and their absolute numbers calculated. (c) For determination of
cytokine production, blood samples were processed and cytokine expres-
sion was analyzed as described in Fig. 2. Data are shown as mean   SD.
#, results differed from the sham-operated group; #, P   0.05; ##, P  
0.01; §, results differed from the diluent-treated MCAO group; §, P  
0.05; §§, P   0.01; §§§, P   0.001. Mann-Whitney U test, n   9–12 per
group. (d) In a different set of experiments, lungs and blood samples from
sham and inhibitor- or diluent-treated MCAO mice were collected for
bacteriological analysis 72 h after surgery. Data are shown as box plots in
CFU/ml (log 10) blood or lung tissue homogenate.T
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B6 mice (Fig. 8 a). Moreover, recombinant IFN-  reduced
bacterial dissemination in peripheral blood and lungs when
administered 24 h, but not 48 h, after cerebral ischemia
(Fig. 8 b).
Discussion
In this study, we provide for the first time experimental
proof that a neuroendocrine-mediated systemic immuno-
suppression after acute central nervous system lesion results
in the development of spontaneous systemic bacterial infec-
tions. Our study provides the long-sought explanation for a
stroke-induced immunosuppressive state. Our findings may
have general implications for the understanding of how se-
vere stress and injury may lead to an increased susceptibility
to bacterial infections. We demonstrate, in an experimental
model, that cerebral ischemia induces long-lasting depres-
sion of the cell-mediated immunity (monocyte deactiva-
tion, lymphopenia, Th1/Th2 shift) associated with spon-
taneous bacteremia and pneumonia. We provide strong
evidence that an impaired early NK and T cell response, in
particular a reduced IFN-   production, is the critical
stroke-induced defect in the antibacterial defense. Thus, ei-
ther adoptive transfer of IFN- –producing lymphocytes
(i.e., NK and T, but not B cells) or early treatment with re-
combinant IFN-   inhibited bacteremia and pneumonia.
Importantly, the occurrence of life-threatening spontane-
ous systemic bacterial infections after experimental stroke
and the defective IFN-  response were only prevented by
blocking the SNS, but not the HPA, suggesting that cate-
cholamine-mediated lymphocyte dysfunction is the key
factor in the impaired antibacterial immune response after
stroke. We call this phenomenon stroke-induced immuno-
deficiency syndrome.
It has been long known that activation of the SNS and
the HPA by proinflammatory cytokines in systemic inflam-
mation results in the release of glucocorticoids and cate-
cholamines, which in turn inhibit further production of
proinflammatory mediators. More recently, another physi-
Figure 5. Prevention of bacterial infections and restoration of defective
IFN-  response by SNS inhibitors is dose and time dependent. (a) MCAO
mice were treated with diluent or different doses of propranolol (3  
1–3   30 mg/kg BW) commencing immediately after MCAO or 24 h
(3   30 mg/kg BW) after MCAO, or with 6-OHDA before MCAO as
described in Materials and Methods and as indicated (n    4 in each
group). Lungs and blood samples were collected for bacteriological analy-
sis 72 h after MCAO. Data are shown as box plots in CFU/ml (log 10)
blood or lung tissue homogenate. (b) In a different experiment, spleens of
untreated mice (control), sham-, or MCAO-operated mice, which re-
ceived diluent, propranolol, or 6-OHDA as described above, were col-
lected 12 or 36 h (delayed propranolol treatment) after surgery. 106/ml
spleen cells were stimulated ex vivo with Con A for 24 h and IFN-  pro-
duction was analyzed by ELISA, as described in Materials and Methods.
Data are shown as mean   SD. #, results differed from the sham-oper-
ated group; #, P   0.05; §, results differed from the MCAO animals; §,
P   0.05. Mann-Whitney U test, n   3–6 per group.
Figure 6. Blocking the SNS improves survival after experimental
stroke. Mice underwent MCAO and received either diluent or 10 mg/kg
BW immediately before, 4, and 8 h after MCAO (n   15 per group).
Differences in survival between propranolol-treated versus diluent-treated
mice were tested for significance on day 11 after MCAO and are indi-
cated by asterisks. *, P   0.05. Fisher’s exact test.T
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ological feedback mechanism termed the “cholinergic anti-
inflammatory pathway” has been uncovered. Activation of
the vagus nerve by inflammatory cytokines during endo-
toxemia was found to inhibit macrophage cytokine produc-
tion through release of acetylcholine (24, 25). The rapid
activation of these pathways in inflammatory conditions
protects the organism against any adverse effects of an over-
whelming immune response. However, an excessive acti-
vation of inhibitory neuroendocrine pathways without sys-
temic inflammation can inappropriately suppress the
immune system and increase the risk of infections. We
have recently reported that the intrathecal release of pro-
inflammatory cytokines is associated with signs of systemic
immunodepression and a high incidence of infections in
neurosurgical patients (21). Increased intrathecal levels of
proinflammatory cytokines like IL-1 , IL-6, and TNF- 
have been found in various brain disorders including
trauma, subarachnoidal hemorrhage, and ischemia, which
are commonly associated with HPA and SNS activation
(22, 26–32). Interestingly, diminished ex vivo endotoxin-
Figure 7. Adoptive lymphocyte transfer after experimental stroke pre-
vents infection. (a) Adoptive lymphocyte transfer was performed 24 h after
MCAO using either unseparated (total) or T, B, and NK cell, or T cell–,
B cell–, or NK cell–depleted spleen cell suspensions from wild-type
SV129/J mice. *, results differed from unseparated splenocyte transfer
group. Kruskal-Wallis analysis of variance (ANOVA) after pairwise com-
parison with Dunn’s method test, n   4 per group. (b) In a different set of
experiments, splenocytes from    T cell–deficient (  -TCR / ),    T
cell–deficient (  -TCR / ), or wild-type B6 mice (WT) were trans-
ferred into B6 mice 24 h after MCAO. 48 h later, blood and lung samples
were analyzed for bacterial counts. Data are shown as box plots in CFU/ml
(log 10) blood or lung tissue homogenate. *, results differed from WT
splenocyte transfer group. Kruskal-Wallis analysis of variance (ANOVA)
after comparison of pairs with Dunn’s method test, n   8 per group.
Figure 8. IFN-  is essential in preventing the bacterial infections. (a)
Adoptive lymphocyte transfer experiments 24 h after MCAO revealed an
impaired ability of splenocytes from IFN- –deficient mice (IFN-  / ) to
prevent bacterial infection in blood and lung when compared with sple-
nocytes from wild-type B6 mice (n   8 per group). (b) Administration of
2  g recombinant IFN-  24 h, but not 48 h, after cerebral ischemia re-
duced the bacterial burden in peripheral blood and lungs as measured 72 h
after MCAO (n   4 per group). For data representation see Fig. 5.T
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induced TNF-  production in rats, after intracerebroven-
tricular TNF-  or IL-1  infusion, was prevented by hypo-
physectomy or  -adrenoreceptor blockade (33), suggesting
that a local increase of proinflammatory cytokines in dam-
aged brain tissue can trigger a systemic immunoinhibitory
response via sympathoadrenal activation (13, 21).
In this study, we demonstrated that pharmacological in-
hibition of the activation of either SNS or HPA prevented
the stroke-induced lymphocyte apoptosis, lymphopenia,
and monocytic deactivation. However, poststroke lympho-
cyte dysfunction (i.e., decrease of IFN-  and increase of
IL-4 production) and bacterial infections were only pre-
vented by SNS inhibitors (propranolol and 6-OHDA) and
not by the glucocorticoid receptor blocker RU486. Cate-
cholamines have been shown to suppress Th1 activities and
cellular immune responses either directly, inhibiting the
IFN-  synthesis by Th1 cells, or indirectly, by inhibition of
Th1-polarizing cytokines like IL-12 and TNF-  produced
by antigen-presenting cells (34). Instead, catecholamines
appear to promote Th2 cell differentiation and cytokine
production (34), and trigger the secretion of IL-10 (a po-
tent inhibitor of Th1 and monocyte functions) by mono-
cytes (13). Because IFN-  stimulates the microbicidal ac-
tivity of phagocytes, whereas IL-4 inhibits phagocytosis, a
decreased ratio of IFN- /IL-4 production indicates a com-
promised antibacterial defense (35). A decreased Th1/Th2
ratio has been found after major surgery or trauma and as-
sociated with lower survival and decreased resistance to in-
fections after major burn injury (36–39). Our data on stress
mediator blockade underline the importance of functional
defects in IFN-  production in the control of infectious
complications after stroke. This conclusion is further sup-
ported by the adoptive transfer experiments: prevention of
bacterial infections by spleen cell transfer depends not only
on T and NK cells, but also on their ability to secret IFN- .
Moreover, we show that early (24 h) but not late (48 h)
administration of recombinant IFN-  greatly reduced blood
and pulmonary bacterial burden, suggesting that a rapid
production of IFN-  by lymphocytes is crucial in control-
ling bacterial infections. Our data support and extend re-
cent findings in models of sepsis and pneumonia suggest-
ing an important role for early lymphocyte responses in
mounting an efficient antibacterial defense (40–42). In mu-
rine models of Gram-negative (Klebsiella pneumoniae) and
Gram-positive (Nocardia asteroides) pneumonia,    T cells
are critical for survival (43, 44). In stroke-induced infec-
tions,    T cells are essential for pulmonary bacterial clear-
ance, whereas    T cells are more critical in the peripheral
blood.
The results of our study may also have important impli-
cations for models of stroke as well as sepsis. The high mor-
tality that we have observed in our study is well known in
rodent models of stroke (45–47) and seems to be largely
dependent on the duration of the MCAO as well as the
strain of animals used (48–51). Previously, the high mortal-
ity was directly attributed to the central nervous system le-
sion (45, 46). Interestingly, the time course of the survival
rate shows two phases. In the first phase (up to day 3)
 13% of the mice die. The mortality in this phase is pre-
dominantly caused by the brain lesion directly. After day 3,
mortality increased dramatically and reached  60% by day
7. The results of this study strongly suggest that this second
phase is a consequence of stroke-induced immunodefi-
ciency syndrome–associated severe infections and not di-
rectly due to the brain lesion because prevention of in-
fection by antibiotic therapy (unpublished data) or by
blockade of SNS (Fig. 6) improves survival dramatically
without affecting infarct size (unpublished data). Although
we have not found a systematic analysis of mortality in
MCAO models in the literature, historic data also suggest a
two phase time course of survival (45, 47, 51–54). Al-
though infectious complications (in particular, bacterial
pneumonia) and their relevance for mortality are well
known in acute stroke (55, 56), these complications have
not been reported previously in experimental stroke. To
our knowledge, this is the first report of a model with
stress-mediated immunodepression promoting spontaneous
systemic bacterial infections. This model will be useful to
further investigate the neuroimmunological mechanisms
contributing to immunodepression and development of in-
fections after trauma and stress, and to evaluate new thera-
peutical approaches to prevent or reverse immunodepres-
sion and its infectious complications.
In stroke patients, the occurrence of pneumonia is of
particular clinical importance. Importantly, the 30-d mor-
tality in patients who developed pneumonia is increased up
to sixfold in comparison with stroke patients not suffering
from pneumonia (55). Because, conservatively estimated, at
least 10% of deaths occurring in stroke patients are attribut-
able to pneumonia, further research to identify patients at
increased risk for pneumonia and alternative approaches for
prevention are needed (55). Additionally, the extent of in-
fectious complications is proportional to the severity of the
initial ischemic deficit (2–4, 55, 56). With respect to stroke
size, our murine model is comparable with large infarctions
in the human MCA region, which may explain the high
incidence of infections in this model. Although pneumonia
is thought to develop in stroke patients most often as a re-
sult of aspiration secondary to dysphagia, not all patients
who aspirate develop infections (57, 58). In addition, up to
a half of patients who develop pneumonia do not aspirate
(59). Thus, although after severe strokes aspiration due to
dysphagia is a known risk factor for pneumonia, other fac-
tors have been postulated that might predispose stroke pa-
tients to pneumonia, e.g., an impaired immune responsive-
ness (57, 58, 60). Our data strongly support this hypothesis
and provide conclusive experimental evidence that aspira-
tion alone is not sufficient for the development of bactere-
mia and pneumonia, for the following reasons. First, we
demonstrated that bacterial infections can be prevented by
propranolol, administration of INF- , as well as by adop-
tive lymphocyte transfer. These interventions, specifically
the latter two, restore the immune function and are un-
likely to prevent only aspiration. Second, the described
changes in immune parameters preceded infections. Third,
antibiotic treatment prevents infection but does not restoreT
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the altered immune profile (unpublished data). Rather, a
defective antibacterial defense after cerebral ischemia is the
main factor that determines the occurrence of systemic bac-
terial infections. However, we cannot exclude that aspira-
tion is a prerequisite for pneumonia in stroke.
In conclusion, we have characterized for the first time a
stroke-induced immunodeficiency that leads to severe bac-
terial infections, which could have important implications
in improving therapy. Prevention of infections in patients
with cerebral infarctions could reduce morbidity and mor-
tality, as chest infections significantly affect the outcome in
stroke patients (61, 62) and preventive antibiotic treatment
reduces neurological deficit and mortality in this model of
stroke by  60% (unpublished data). In addition to anti-
microbial approaches, immunotherapeutic approaches, such
as inhibition of lymphocyte apoptosis (e.g., by caspase in-
hibitors) or use of immunostimulatory drugs (e.g., IFN- ,
GM-CSF), may help to prevent or even reverse inappro-
priate immunodepression and decrease the risk of infectious
complications after stroke. Considering the currently lim-
ited arsenal of stroke therapies, these new strands of treat-
ment may significantly improve the clinical outcome.
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